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SUMMARY.-An assay is described for measuring the concentration ofspecific,
high-affinity oestradiol receptors in the cell supernatant fraction of breast
tumour biopsies. The method has been applied to biopsies from 94 patients
with malignant and benign diseases of the breast. Of the 53 biopsies classified
as carcinomas, 37 contained high-affinity oestradiol receptors in concentrations
ranging from 0-3-22-6 x 10-15 moles/mg. tissue, 2 were borderline, and 14
did not contain any receptor. The proportion of positive results and the range
of concentrations were found to be somewhat higher in postmenopausal than
in premenopausal patients. Despite detailed examination, no histological
feature was found which could explain the variation in receptor concentration;
neither could it be accounted for by differences in the cellularity of the biopsies.
Of the 41 benign breast biopsies examined only 3 contained any high-affinity
oestradiol receptor and in these the concentration was very low, ranging from
0
-3-0.6 x 10-15moles/mg. tissue. The receptor has not been detected in normal
breast tissue. The relationship between the presence of oestrogen receptors
and hormone responsiveness in tumours is discussed.
TIIE role of specific oestrogen receptors in mediating the action of oestrogens
in target organs has received considerable attention in recent years. Macro-
molecular oestrogen receptorsiiiitially identified in the uterus andvagiiia have also
been found in some mammary turnours. Their presence in these organs is associa-
ted witli a high uptake and prolonged retention of oestradiol in the intact animal
(Jensen, DeSombre andJungblut, 1967). Receptors occur in both thecytoplasmic
and nuclear fractions but thepreciserelationship between the two types ofbinding
sites and the mechanisni by which they initiate oestrogen action are not yet
clearly established (Gorski et al, 1968; Jensen et al., 1968).
The presence of oestrogen receptors has been demonstrated in hormone-
dependent tumours inexperimental animals. notably in somedimethylbenzanthra-
cene-induced mammary tumours in the rat and in oestrogen-induced kidney
tumours in the hamster (King, Smith and Steggles, 1970; Mobbs, 1966; Sander
and Attran-iadal, 1968). These receptors do not appear to be present in autono-
mous tumours in these organs and this observation suggests that the presence of
oestrogenreceptors may be a characteristic feature ofhormone-dependenttumours.
In cases ofhuman breast carcinomathe establishmentofsuch acriterionwouldbeof
potential clinical value in selecting patients for hormone therapy or endocrine
ablatioii. A study by Folca, Glascock and Irvine (1961) has already indicated a
link betweenhormone-depei-idence ofbreast cancers andtheirability to accumulate
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studies on a large scale have led to a search for simpler methods of assessing
oestrogen receptor activity in vitro. Ideally such methods should be suitable
for routine application to breast biopsy samples.
Like other target organs, tumour tissue contains both high-affinity and low-
affinity oestrogen binding sites and considerable difficulty has been experienced
in differentiating between these two types. The former sites are thought to
mediate the cellular action of oestrogens whereas the latter probably represent
non-specific binding. For this reason, methods involving simple measurement of
oestrogen uptake by tissue slices lack specificity (Sander, 1968) but this problem
may be overcomebycomparing the uptake of labelled oestradiol in the presence
or absence of specific oestrogen antagonists or in the presence and absence of
excess of unlabelled carrier. Using the former technique, Jensen's group have
found oestrogen receptors in approximately 50% of the primary tumours and
30% of the metastic tumours examined (Jensen et al., in press; Brecher et al.,
1971). Johansson, Terenius and Thoren (1970) found significant binding in 14
out of 31 malignant tumours but in only 2 out of 26 benign tumours and no
binding in normal tissue. Korenman and Dukes (1970) studied the binding of
oestradiol to isolated tumour cytosol fractions and by comparing the relative
binding affmities of various competitors, established that substantial specific
oestradiol bincling occurred in 5 out of 15 tumours examined. In a preliminary
study, Feherty and Kellie (1971) found high-affmity oestradiol receptors in the
cytosol fraction of I1 out of 15 malignant tumours but none in benign or normal
tissues.
At present, none of these studies provides sufficient evidence to establish a
definite link between the oestrogen binding activity measured in vitro and subse-
quent response to therapy. The aim -of the present study was to extend the
previous investigation using a rapid and sensitive technique originally applied to
rabbit and rat uterine cytosols (Mester, Robertson, Feherty and Kellie, 1970;
Feherty, Robertson,, Waynforth and Kellie, 1970) to measure the concentration
ofhigh-affinity oestrogen receptor sites in low-speed tumour supernatant prepar-
ations and to relate the results to the histological and chnical data currently
available.
MATERIALS AND METHODS
[2,4,6,7_3H10estradiol-17)6(100Ci/Mmole) was obtained from the Radio-
chemical Centre, Amersham, Bucks, and was stored in benzene (20ng./inl.) at
8-10' C. It was purified at regular intervals by chromatography on Sephadex
LH-20 and purity was also assessed by thin layer chromatography oii silicagel in
two systems: (cyclohexane-ethyl acetate 13/7 and chloroform-acetone 9/1 v/v).
Aqueous solutions of radioactive oestradiol were stored at 4' C. for up to two
weeks. Buffer solution contained, I mm-EDTA and 250 mm-sucrose in
10 mm-tris-HCI buffer pH 8-0. The dextran-charcoal suspension contained
0-0025% dextran (mol. wt 60,000-90,000) and 0-25% Norit A in buffer solution
(Korenman, 1968). Details of the counting techniques employed have been
published (Mester et al., 1970).
Tumours
Tumour tissue (>, 100 mg.), obtained from breast biopsy samples sent to the
histopathologydepartment(Bland-SuttonInstitute) forfrozensectionexamination,699 OESTRADIOL RECEPTORS IN THE BREAST
was stored at 4' C. untilassayed for oestradiolreceptorcapacity. Noattempt was
made to select tumours for assay although some were discarclecl when less than
100 mg. of tissue was available. Malignant and benign tumours were treated in
exactly the same manner and whenever possible assays were made on the same
day. When this was notpossi'ble the whole tissue was frozen in buffer and stored
at IO' C. for up to oneweek; this treatmenthad nosignificanteffect onoestrogen
receptor concentration. Storage of the whole tissue on ice overnight was also
without effect butfreezing andthawing ofthelow-speedsupernatant resulted in a
decrease in binding capacity of up to 50%; prolonged storage of the frozen
supernatant for up to 4 weeks at -IO' C. produced no further decrease.
Preparation ofthe supernatant
Surroundingfat, connective tissue and necrotic areas were trimmed away from
the tumour. The remaining tumour was weighed, finely minced and suspended
in 10-20 vol. of homogenizing medium (buffer solution and 0-25 m-sucrose gave similar results). Homogenization was carried out in a Silverson tissue disinte-
grator using three 10-second periods ofhomogenization at low speed, with longer intervals ofcooling in ice. These conditions were found togive maximal recovery of the oestradiol receptor although microscopic examination of the resulting homogenate showed that disruption ofthe tissue was not always complete. The
use ofhigherspeeds orlongerperiods ofhomogenization resulted in a reduction of
the oestradiol-binding capacity. The homogenate was centrifuged for 15 min.
at 1000 X g at 4' C. and the supernatant separated from the nuclearpellet.
The establishment of assay conditions
The method of determining the oestradiol receptor concentration of tumour
supernatant preparations was similar to that already published for rabbit ancl rat
uteri (Mester et al., 1970; Feherty et al., 1970). Portions ofthe supernatant were
incubated with a range of concentrationsof [3H]oestradiol until eqailibrium was
reached. At this point the equilibrium mixture contained free oestradiol and
oestradiol bound to both high-affinity and low-affinity sites. Dextran-charcoal
was'then added to adsorb free oestradiol, and incubation was continued for a
further period. Under these conditions the relatively rapid rate of dissociation
of the low-affinity complex resulted in a selective removal of oestradiol bound to
low-affinity sites. The oestradiol remaining bound to high-affinity sites was
measured by scintillation counting and the resultsplotted as the ratio of
"bound/ free
" oestradiol against
" bound
" oestradiol (Scatchard, 1949). On this graph (Fig. 2) the intercept on the abscissa (Po) represents the molar concentration of
high-affinity binding sites in the preparation. The dissociation constant (Kd) for the oestradiol-receptor complex can also be determined from the slope of the
graph. In order to establish the optimal conditions for reaching equilibrium and for removing oestradiol bound to the low-affinity sites, the following experi- ments were carried out:
I - Temperature-time course of the reaction. Portions of tumour supernatant (0-1 ml.) were incubated with [3H]oestradiol (5pg./O-I ml. of buffer) at various
temperatures for periods of time up to 24 hours. The reaction was stopped by adding dextran-charcoal suspension (0-5 ml.) and the mixture was incubated for
a further IO minutes at 30' C. The mixture was centrifuged at I000 x g for700 P. FEHERTY, G. FARRER-BROWN AND A. E. KELLIE
5 minutes at 4' C. and 0-5 ml. oftheresulting supernatant was transferred to vials
for scintillation counting.
Fig. I shows the time courses for the binding reaction at various temperatures
in the presence ofthe minimum oestradiol concentration employed in the routine
assayprocedure. At 4' C. ittookapproximately 24 hours forthe reaction to reach
equilibrium; at 20' C. equilibrium was achieved within 2 hours and the resulting
complex was stable for a considerable period of time. At 30' C. equilibrium was
reached within 20-30 minutes but the complex was slightly unstable at this
temperature and a slow degradation occurred over a period of hours. At 370 C.
the complex deteriorated very rapidly. For reasons of convenience an equilibra-
tion period of 30 minutes at 30' C. has been used as a routine procedure in the
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FIG. I.-Time courses at various temperatures for the bindingof [3H]oestradiol to the
high-affinity receptor in the supematant fraction of a malignant biopsy.
receptor assay. Theslightinstability ofthe complex under these conditions leads
to an underestimate of the final result by approximately 5 The use of a
longer period ofequilibrium at a lower temperature, e.g. 2 hours at 20' C. would
be more desirable for this reason and also because the lower dissociation constant
at this temperature results in a higher percentage of the oestradiol being bound
at low concentrations. This would give improved sensitivity. Fig. 2 shows a
comparison of Scatchard plots obtained by incubating for 30 minutes at 30' C.
and for 2 hours at 20' C. It can be seen that the difference in value ofP, is small.
2. Dissociation of complexes on incubation with charcoal.-Portions of tumour
supernatant (0-1 ml.) were incubated with [3H]oestradiol (I00 pg. in 0-I ml. of
.buffer) for 30 minutes at 30' C. to form high-affinity and low-affinity complexes.
Dextran-charcoal suspension (0-5ml.) was added to each tube and the incubation
was continued withshaking at 20' C. and at 30' C. forperiods up to 2 hours. At
the.end of each incubation the samples were cooled in ice and centrifuged at701 OESTRADIOL RECEPTORS IN THE BREAST
1000 X g for 5 minutes at 4' C. A portion (0-5ml.) ofthe resulting supematant
was transferred for scintillation counting.
Fig. 3 shows a semi-log. plot of the time-courses for dissociation of bound
[3H]oestradiol on incubation of a previously equilibrated supematant with
dextran-charcoal suspension at 20' C. and 30' C. The initial rapid component
of each curve represents dissociation of the non-specific, low-affinity oestrogen
binding sites which are present in all tumour preparations. The second, slow
component represents the much slowor dissociation of the specific, high-affinity
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FiG. 2.-Scatchard plot for the equilibrium between [3H]oestradiol and high-affinity receptor
after incubation at 20' C. for 2 hours or at 30' C. for 30 minutes. P,, represents the molar
concentration of high-affinity receptor sites present in the reaction mixture. The slope of
ea.h line is equal to IlKd, where Kd is the dissociation constant for the oestradiol-
receptor complex at the appropriate temperature.
receptor sites. The graph also shows that dissociation of the low-affinity sites
is virtually complete within 10 minutes at 30' C. or 15 minutes at 20' C., whereas
only a very smallpercentage ofthehigh-affinity sites dissociates inthis time. The
velocity constants for dissociation of the high-affinity ancl low-affmity complexes
(k-, and k-2respectively) at 20' C. and 30' C. were as follows:
200 C. 300 C.
k-, (high-affinity) 0-4 X 10-4sec.-l 1.5 X 10-4 see.-'
k-2 (low-affinity) 3-2 X 10-3sec.-1 3-8 X 10-3sec.-l702 P. FEHERTY, G. FARRER-BROWN AND A. E. KELLIE
The incorporation of a 10-minute charcoal incubation period into the routine
assay procedure thus achieves the selective removal of oestradiol bound to the
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FIG. 3.-Dissociation of the low-affmity and high-affmity oestradiol-receptor complexes during incubation withdextran-charcoalsuspension at 20' C. (A) and 30' C. (40),plotted on
asemi-logarithmic scale. The two upper curves represent a mixture oflow-affmity (rapidly dissociating) and high-affmity (slowly dissociating) sites. The two lower lines represent dissociation oflow-affinity sites only.
low-affmity sites. The effect ofthis step on the Scatchardplot is shown inFig. 4.
Without the charcoal incubation step a curved plot is obtained which represents
binding to a mixture of high-affinity and low-affinity sites; from this curve a
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determination of P,, the concentration of high-affmity sites, is not possible.
When the charcoal incubation step is included a linear plot is obtained which
represents binding to high-affmity sites only.
Routine assay ofoestrogen receptor concentration
Portions oftumour cytosol (0-1 ml.) were incubated with a range of concentra-
tions of[3H]oestracliol (5-10 pg. in 0-1 ml. ofbuffer; 5 duplicate points per assay)
for 30 minutes at 30' C. Dextran-charcoal suspension (0-5 ml.) was then added
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FiG. 4.-The effect of charcoal incubation on the Scatchard plot. Curve A shows the result
obtained when charcoal incubation is omitted, and represents a mixture of both high- afl'mity and low-affinity receptor sites. Line B demonstrates the effect of incubating with dextran-charcoal suspension for 10 minutes at 30' C.: thelow-affinity component ofthe
curve is eliminated and astraight line is obtained which representshigh-affmity sites only.
to each sample and the incubation was continued with constant shaking for a
furtherperiod of 10 minutes at 30' C. Thesamples were cooleclinice, centrffuged
at 1000 X g for 5 minutes at 4' C. and a portion (0-5MI.) ofthe resulting super-
natant was transferred forliquid scintillation counting. [3H]Oestradiol standards
and blanks (controls which were incubated with charcoal) were prepared and
counted under the same conditions.
Determination ofDNA
The DNA content of the nuclear pellet was determined by the method of
Burton (I956).
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Assessment of[3H]oestradiol metabolism by tumour supernatants
Supernatants from severalbenign andmalignant tumours, selected atrandom,
were incubated with [3H]oestradiol under conditions similar to those used in the
assay. The radioactivity was then extracted with ether, evaporated to dryness,
and purity was assessed by chromatography on Sephadex LH-20 in benzene-
ethanol (85 : 15). A single peak was obtained in the oestradiol region and there
were no detectable metabolites.
Histological examination
Immediately the breast biopsies were received from the operating theatre
they were examined macroscopically and by frozen section. A portion of tissue
adjacent to the area sectioned was removed for oestradiol receptor assay. The
frozen section material and blocks of the remainder of the biopsy were then pro-
cessed routinely for histological examination. All sections of the biopsies in this
study have been reviewed andgradedaccording to the World Health Organization
classification of breast tumours (Searff and Torloni, 1968). The 53 carcinomas
were divided into low, average or high grade according to the degree of tubule
formation, pleomorphism ofthe cells and number ofmitoticfigures perhigh power
field. In addition theproportion ofintraduct carcinoma and invasive tumour was
assessed. The ratio of the mass of tumour cells to the mass of the surrounding
connective tissue was estimated and the histological type of cells composing each
tumournoted.
The 41 biopsies with benign tumours were divided into those patients with
fibroadenomas, either pericanalicular or intracanalicular, and those with features
ofbenign mammary dysplasia (Searff and Torloni, 1968). In the latter biopsies
the presence and extent ofadenosis, epitheliosis, fibrosis, duct ectasia and stagna-
tion, apocrine metaplasia, inflammatory cell infiltrate, fat necrosis and small
cyst formation were assessed.
RESULTS
Malignant tumours
The results obtained for the oestradiol receptor concentration in 53 breast
biopsies invaded by carcinoma are shown in Table 1. Arranged in order of
increasing receptor concentration, the results show 14 tumours in which no
oestradiol receptors were detected, two which were considered to be borderline
samples, and 37 which contained high-affmity oestradiol receptors ranging in
concentration from 0-3-22-6 x 10-15moles/mg. In order to assess the cellularity
ofthe tissue the DNA content was measured inapproximately halfofthesamples.
Although this parameter varied considerably, the general trend ofthe results was
similar whether the receptor concentration was expressed per mg. of tissue or
per ag. DNA.
The influence ofmenopausal status on the distribution of oestradiol receptors
is of interest. Of the cases diagnosed as carcinoma, 14 were premenopausal,
36 postmenopausal and 3 were unknown. In the premenopausal women the
oestradiol receptor concentration ranged from 0-2-3 X 10-15moles/mg. with a
mean value of 0-6 x 10-15. Zero values were obtained in 6 of the 14 cases and
one was borderline. In the postmenopausal women, the values ranged fromOESTRADIOL RECEPTORS IN THE BREAST 705
TABLE I.-Clinical Data and Oestradiol Receptor Concentration in Breast
Cancer Biopsie8
Oestradiol receptor
conen. X 1015
Histological
A
Age of Menopausal grade of (moles/mg. (moles/yg. Kd X I0'0
Case No. patient status tumour tissue) DNA)
12 80 Post High 0 0
16 45 Pre High 0 0
21 72 Post Av. 0 0
35 47 Post Av. 0 0
37 75 Post Intraduct 0 0
43 42 Pre Av. 0 0
48 63 Post Low 0 0
55 43 Pre Av. 0 0
56 71 Post Av. 0 0
58 56 Post High 0 0
65 45 Pre Av. 0 0
72 46 Pre Low 0 0
78 35 Pre Intraduct 0 0
93 59 Post High 0 0
49 60 Post Av. ?
52 60 Post Av. 9
86 70 Post High 0- 3 1:5
6 62 Post Low 0-4 1.5
15 45 Pre High 0-4 2-0
66 77 Post Low 0-4 0-2 3-0
62 58 Post Av. 0-4 0-4 1.0
81 49 ? High 0- 6 0- 2 2-5
26 54 Pre Low 0- 7 3
-2
85 69 Post Av. 0- 8 0-3 2- 7
17 63 Post Av. 0.9 1.5
1 70 Post Av. 0.9 2- 7
41 38 Pre (o.c.) Low 0.9 2
-3
90 42 Pre Av. 0.9 2-0
7 56 Post Intraduct 1.1 2-1
30 46 Pre Low i-2 2
- 6
29 56 Post Av. 1-4 1.9
44 46 ? Low 1-5 0- 6 4-5
28 48 ? Low 1- 7 2-5
59 47 Post Av. 1-8 1-2
23 65 Post Low 2-0 5.0
89 26 Pre (o.c.) Av. 2
-0 2-0
53 59 Post Av. 2
- 3 0-4 1-5
33 39 Pre Av. 2
- 3 3-4
3 67 Post Av. 2-4 2- 7
13 50 Post Av. 2
- 5 1-5
54 69 Post High 3
- 6 1.5 3- 8
31 56 Post Low 3
- 9 2-6
94 78 Post Av. 5.0 4-0
92 68 Post Av. 5-4 1.9
14 59 Post Av. 5.5 2-1
27 62 Post Av. 7- 3 5-2
5 64 Post High 8
-0 5-0
74 66 Post High 8- 3 3
-9 3
- 3
9 66 Post Av. 9-4 1- 7
73 54 Post Av. 10-4 3
- 9 3-3
46 73 Post Av. 12-0 5- 7 5-0
8 70 Post Av. 13-9 1-3 87 54 Post Av. 22- 6 2
- 8
AbbreviatiOM: Av.-average grade malignancy. o.c.-patient known to be taking an oral contraceptive.706 P. FEHERTY, G. FARRER-BROWN AND A. E. KELLIE
0-22-6 X 10-1-5 with a mean of 3-7 x 10-15. Of the 36 samples examined, 8
gave a zero result and one was borderline.
The dissociation constant (Kd) observed for the oestradiol-receptor complex at
30' C. ranged from 1-5 x 10-1 0 m. This variation may be partly due to the
error involved in determining the slope of the Scatchard plot, but the apparent
TABLE II.-Clinical Data and Oestradiol Receptor Concentrations in
Benign Breast Biopsies
Oestradiol receptor
concn. x 103L5
(moles/mg. tissue)
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0-3
0-4
0-6
Age of
patient
35
48
46
64
49
41
36
52
46
51
55
49
51
39
33
43
20
47
47
33
25
26
43
46
45
37
40
43
47
43
41
40
38
45
19
47
60
44
37
39
19
Menopausal
status
Pre
Pre
Pre
Post
Pre
Pre
Pre
Post
Pre
Pre
Post
Pre
Post
Pre
Pre
Pre
Pre (o.c.)
Pre
Pre
Pre
Pre
Pre (o.c.)
Pre
Pre
Pre
Pre
Pre
Pre (o.c.)
Pre
Pre
Pre
Pre
Pre
Pre
Pre
Pre
Post
Pre
Pre
Pre
Pre (o.c.)
Kd X 1010
(m)
4-5
3-0
2-1
Case No.
4
I1
18
19
20
22
24
25
32
34
36
38
39
40
42
45
47
50
51
57
60
6i
63
64
68
69
71
75
67
76
77
79
80
83
88
95
96
97
82
91
70
Histology
BMD
Fibroadenoma
BMD
BMD
BMD
Fibroadenoma
BMD
BMD
BMD + Cyst
BMD
Fat necrosis
BMD
BMD
Fibroadeno'ma
Fibroadenoma
BMD + Cyst
BMD
BMD
BMD
Fibroadenoma
Fibroadenoma
Fibroadenoma
BMD
BMD
BMD
BMD
Fibroadenoma
BMD
BMD
BMD
BMD
BMD
Fat necrosis
BMD
Fibroadenoma
BMD
BMD
BMD
Fibroadenoma
Fibroadenoma
Fibroadenoma
Abbreviation8: BMD-benign mammary dysplasia.
O.C. Patient known to be taking an oral contraceptive.
value of the constant is also influenced by factors such as the concentration of
endogenous oestradiol and the relative amount of low-affinity receptor present.
Bearing in mind these limitations it is likely that the same type of receptor is
involved in all cases.
The histological grading of each carcinoma is shown in Table I. The tumourOESTRADIOL RECEPTORS IN THE BREAST 707
was entirely intraduct in three biopsies, two of which were devoid of oestradiol
binding sites, while the third case had a level of 1-05. The ten high grade car-
cinomas had oestrogen receptor levels between 0 and 8-3, the 29 average grade
tumours between 0 and 22
-6 and the II lowgrade tumours between 0 and 3
-9.
A study of the cells composing each carcinoma showed three different types.
First a small round cell reminiscent ofthe cell seen in salivarygland tumours and
thought to have a myoepithelial origin. Secondly, a large adenomatous epithe-
lial cell with appearances suggesting origin from the lining breast duct epithelium
and thirdly a cell intermediate between the first two types of cell. Although a
slightly greater proportion of the negative oestrogen-receptor carcinomas were
composed of the first type of cell compared with the positive receptor carcinoma
cases no significant correlation was found between the carcinoma cell type and
oestrogenbinding level.
No other histological feature was seen which might explain the variation in
oestrogenbinding levels ofthe biopsies invadedby carcinoma.
Benign breast disease and normal tissue
Ofthe 41 benign breast biopsies shown in Table 11, evidence ofspecific oestra-
diolbinding was found inonly 3, and in these the receptor concentration was very
low, the maximum value being 0-6 x 10-15moles/mg. Thirty-six of the 41
patients were premenopausal, including the 3 which gave a positive result. Four
ofthe patients were known to betaking an oral contraceptive, one ofwhom had a
positive receptor level.
Histologically, this group consisted of 27 biopsies with features of benign
mammary dysplasia, 2 with fat necrosis and 12 with fibroadenomata (Table II). The 3 positive cases with oestradiol receptor levels of 0-3, 0-4 and 0-6 were fibro-
adenomata, predominantly pericanalicular in type and in 2 ofthem myoepithelial cells surrounding the breast tubules were prominent and vacuolated, but overall
they could not be distinguished histologically from the other 8 fibroadenomata.
The majority of biopsies with benign mammary dysplasia showed adenosis, fibrosis, duct ectasia and stagnation. Inflammatory cell inffltrates were usually
scanty while apocrine metaplasia, small cysts and minor epitheliosis were present only in aminority ofsections. Severeepitheliosis was not seen.
No oestrogen sites have been found in samples classified as normal or in areas
of uninvaded tissue surrounding tumours.
DISCUSSION
The results of this study confirm that a high proportion of human mammary carcinomas containspecifichigh-affinityoestradiolreceptors which arenotdetected
in normal breast tissue or in the majority of benign lesions. These results are
consistent with the finding that some but not all breast cancers can concentrate
oestrogens in vivo (Folca, Glascock and Irvine, 1961; Demetriou et al., 1964; Desphande et al., 1967; Braunsberg, Irvine and James, 1967; Pearlman et al.,
1966) and also with in vitro studies which have shown by various methods that
some breast tumours contain specific oestrogen receptors similar to those found
in the uterus (Jensen et al., in press; Korenman and Dukes, 1970; Johansson, Terenius andThoren, 1970).
The assay technique used in the present study has the advantages of being708 P. FERERTY. G. FARRER-BROWN -A-ND A. E. KELLIE
simple, quantitative andsuitable for routineapplication. Aresult can be obtained
on asinglebiopsvsample within a few hours. and 20samples can easilv be handled
by one person m a dav. Onlv 100 mg. of tissue is required per assav and the
amount of isotope consumed is verv small. The use of the charcoal ineubation
procedure to eliminate binding to non-speeifie low-aflinitv sites results in an
improved accuracy and sensitivitv. This mav account ior the proportion of
positive results obtained being hig.er than in comparable studies using different
techniques. It is uncertain whether a zero result represents a complete absence
of oestradiol receptors or simplv a concentration below the hmits of sensitivity
ofthe assav (approx. O-I x IO-.5moles/mg.). However. in most ofthesesamples
no oestra&I was bound whatsoever. although in a fe'w cases there was slight
residual binding of up to I ',' ofthe labeHed oestradiol to low-afliDitv receptors.
In considering the variabilitv ofoestrogen reeeptor concentration in the malig-
nant tumours, the effect of endogenous hormone must be taken into account.
The assav method measures onlv vacant receptor sites. Those sites alreadv
occupied bv endogenous hormone are largelv excluded because the slow rate of
dissociation ofthe complex permits onlv a smallproportion ofthem to equilibrate
under the conditions emploved. In o.der to measure the total number of sites.
it would therefore be necessarv t-o determine the amount ofendogenous oestrogen
bound in each tumour supernatant. -Although this was attempted. there was
insufficient material available in most cases for accurate estimation. Thus in
tumours which contained significant levels of endogenous oestrogen the result
obtained mav represent an underestimate of the true oestrogen receptor capaeitv.
This could partlv aceount for the faet that the measured reeeptor eapacities of
tumours from premenopausal women were on average lower than those of post-
menopausal women. However. it has been found that in rat uterine supematants
the fraction of the total reeeptor sites occupied bv endogenous oestradiol never
exceeds 10% of the total (Fehertv et al.. 1970). if a similar situation exists in
breast tumours the effect ofendogenous hormone would be negligible.
X.o histological feature was found which micrht explain the variatioii in levels
of oestradiol receptor in the carcinomas. -Neither the proport-ion of tumour to
surrounding connective tissue. nor the grading of the tumour according to the
W.H.O. Classification of Breast Tumours correlated with the varying oestrogen
binding levels. The 3 intraduct carcinomas had negative or low levels but some
purelv invasive carcinomas also had negative binding sites. Similarlv there was
no correlation with the ext-ent of invasion bv the carcinoma or the cell type
composing the tumour.
Thirtv-eight ofthe 41 patients considered histologieallv to have benign condi-
tions of'the breast had negative oestrogen binding siie estimations. The 3
positive cases showed benign fibroadenomata which were predominantlv peri-
canahcular in type. In 2 ofthese tumours the mvoepithelial cells were vacuolated
andprominent but there was no suspicion of a malignant ehange and there was no
histological feature to distinguish them from the 8 other fibroadenomata. The
2 cases with fat necrosis ofthe breast showed no remarkable histolooical features.
Theremaining 28benign biopsies afl with negative oestrogen binding sites showed
the complete range of histolo cal appearances associated with benign mammarv
dvsplasia although no mark-ed epitheliosis was seen.
Xo obvious explanation has been found for the absence ofoestrogen receptors
in the majoritv of benign biopsies. Although the eellularitv of these samplesOESTRADIOL RECEPTORS IN THE BREAST 709
was generally lower than in the carcinomas, the difference was not sufficient to
account for the failure to detect any receptors. However, the results are consis-
tent with those obtained by Johannsson, Terenius and Thoren (1970) who found
significant oestradiol binding in only 2 out of 26 benign tumours.
All the malignant biopsies studied were from primary tumours, except for
case No. 62 which appeared to be a recurrence of a carcinoma in the other breast
which was removed by mastectomy 7 years previously. Treatment in all cases
consistedofmastectomyfrequentlyfollowedby a course ofradiotherapydepending
on the extent oflymph node involvement. As the duration ofthis survey was less
than 2 years, information on follow-up of the patients is very incomplete. One
patient with advanced disease (No. 17) died shortly after operation and another
(No. 23) has developed metastases in the region of the mastectomy scar and in
the spine but as yet none ofthe others have shown anysign of recurrence. None
of the patients has received steroid therapy. An evaluation of the potential clinical usefulness of the assay is, therefore, not possible from the results of this
survey atpresent. However, theresultsofJensenetal.(inpress)indicate apositive correlation between a high concentration ofoestrogen receptors and a favourable
response to endocrinetherapy. Confirmationofthesefindingswillonlybeobtained
by along-term study of a verylarge number ofpatients.
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